US President Trump has announced plans to levy hefty tariffs, possibly 20–26%, on pharmaceutical imports. The move could ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

European pharma companies warned the European Commission president in a meeting on Tuesday that U.S. President Donald Trump's ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest ...

President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” ...

Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

Anderson notes that biopharma has been sheltered from tariffs for decades, including during the first Trump administration, however this time around the administration placed tariffs on pharmaceutical ...

Previously implemented tariffs on pharmaceutical imports from China (raised from 10% in February to 20% in March) appear ...

Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...